13.10.2012
- Applikon Biotechnology, a private Dutch company specialized in the development, manufacture and supply of bioreactor systems for both research and production use, has started the...
09.10.2012
- Evonik Industries, a manufacturers of specialty chemicals, plans to continue expanding its commitment to biotechnology. "Biotech opens up interesting opportunities for profitable...
06.10.2012
- The Obama administration's reluctance to push for 12 years of data protection on "biologic" medicines in free-trade talks is a growing concern for U.S. drug manufacturers who...
04.10.2012
- From its base in a business park outside the city of Ghent, Belgium's biotech industry is attracting a global following, benefiting from years of patient investment, promising...
03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
25.09.2012
- Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have each raised or are raising funds this year...
21.09.2012
- Syngenta, the world's No.1 agrobusiness company, is buying Belgian seed firm Devgen for €403 million ($522 million), paying a hefty premium to boost its position in rice and close...
18.09.2012
- Johnson & Johnson is stepping a drive to tap into emerging healthcare technology by establishing new innovation centres in four of the world's biotech hot spots - California...
18.09.2012
- Billionaire German investor Dietmar Hopp is betting another €80 million ($105 million) on CureVac, a pioneer of vaccines based on a molecule related to DNA, in one of the biggest...
